188 related articles for article (PubMed ID: 35153505)
1. Protein Phosphatase 1 Regulatory Subunit 3: A Prognostic Biomarker in Stomach Adenocarcinoma.
Zhu YZ; Liao XW; Yin W; Wei HM
Int J Gen Med; 2022; 15():1131-1146. PubMed ID: 35153505
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
3. High Endothelin Receptor Type A Expression as an Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Stomach Adenocarcinoma.
Yan Y; Nie K; Zheng J; Jiang X; Huang Y; Zheng Z; Wen Y; Li P
Cancer Manag Res; 2021; 13():5013-5026. PubMed ID: 34234547
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer.
Zhao W; Lin J; Cheng S; Li H; Shu Y; Xu C
PeerJ; 2023; 11():e14645. PubMed ID: 36919165
[TBL] [Abstract][Full Text] [Related]
5. Cytokine-Like Protein 1 (CYTL1) as a Key Target of M-Stage Immune Infiltration in Stomach Adenocarcinoma.
Zhou F; Lin Q; Zheng Z
Biomed Res Int; 2023; 2023():2926218. PubMed ID: 36825034
[TBL] [Abstract][Full Text] [Related]
6. Increased
Zhaoran S; Linnebacher CS; Linnebacher M
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046730
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive bioinformatic analysis of mind bomb 1 gene in stomach adenocarcinoma.
Wang D; Wang QH; Luo T; Jia W; Wang J
World J Gastrointest Oncol; 2023 Jul; 15(7):1295-1310. PubMed ID: 37546549
[TBL] [Abstract][Full Text] [Related]
8. Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients.
Zha Z; Zhang P; Li D; Liu G; Lu L
Dis Markers; 2021; 2021():8895723. PubMed ID: 33680217
[TBL] [Abstract][Full Text] [Related]
9. A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma.
Ye Z; Zheng M; Zeng Y; Wei S; Huang H; Wang Y; Liu Q; Lin Z; Chen S; Zheng Q; Chen L
Front Oncol; 2021; 11():612952. PubMed ID: 34235071
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ITGB1-DT expression delays the growth and migration of stomach adenocarcinoma and improves the prognosis of cancer patients using the bioinformatics and cell model analysis.
Jiang N; Guo Q; Luo Q
J Gastrointest Oncol; 2022 Apr; 13(2):615-629. PubMed ID: 35557569
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Characterization of Transforming Growth Factor Beta Receptor 1 in Stomach Adenocarcinoma Identifies a Prognostic Signature for Predicting Clinical Outcomes and Immune Infiltrates.
He Y; Zhang H; Zhang Y; Wang P; Zhu K; Ba Y
Int J Gen Med; 2022; 15():3375-3391. PubMed ID: 35368798
[TBL] [Abstract][Full Text] [Related]
12. DOCK4 as a Potential Biomarker Associated with Immune Infiltration in Stomach Adenocarcinoma: A Database Analysis.
Lu Y; Yu J; Dong Q; Du Y; Liang Z
Int J Gen Med; 2022; 15():6127-6143. PubMed ID: 35846794
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value and therapeutic potential of NEK family in stomach adenocarcinoma.
Zhou X; Nie H; Wang C; Yu X; Yang X; He X; Ou C
J Cancer; 2024; 15(10):3154-3172. PubMed ID: 38706902
[TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of a Cancer-Testis Antigen-Related Signature to Predict the Prognosis in Stomach Adenocarcinoma.
Bian G; Cao J; Li W; Huang D; Ding X; Zang X; Ye Y; Li P
J Cancer; 2024; 15(11):3596-3611. PubMed ID: 38817874
[No Abstract] [Full Text] [Related]
15. A Prognostic Signature Constructed by
Han S; Zhu W; Yang W; Guan Q; Chen C; He Q; Zhong Z; Zhao R; Xiong H; Han H; Li Y; Sun Z; Hu X; Tian J
Front Genet; 2021; 12():646818. PubMed ID: 34512711
[TBL] [Abstract][Full Text] [Related]
16. High Expression of ERK-related RASGRF2 predicts Poor prognosis in patients with Stomach Adenocarcinoma and correlates with M2 macrophage.
Du Y; Wang Z; Wan W
J Cancer; 2021; 12(23):7177-7189. PubMed ID: 34729119
[No Abstract] [Full Text] [Related]
17. Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma.
Guo L; Liu D
Eur J Med Res; 2022 Aug; 27(1):164. PubMed ID: 36045400
[TBL] [Abstract][Full Text] [Related]
18. Identification of the key miRNAs associated with survival time in stomach adenocarcinoma.
Liang L; Zhang L; Cui D; Yang D
Oncol Lett; 2017 Oct; 14(4):4563-4572. PubMed ID: 29085454
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide analysis to identify a novel microRNA signature that predicts survival in patients with stomach adenocarcinoma.
Luo SS; Liao XW; Zhu XD
J Cancer; 2019; 10(25):6298-6313. PubMed ID: 31772663
[No Abstract] [Full Text] [Related]
20. Bioinformatics analysis of the prognostic and immunotherapeutic significance of NPRL2 in stomach adenocarcinoma.
Pi Y; Zhan Y; Song J; Jin X; Chen J
J Gastrointest Oncol; 2022 Aug; 13(4):1589-1604. PubMed ID: 36092347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
